Documents
Application Sponsors
ANDA 074586 | ACTAVIS MID ATLANTIC | |
Marketing Status
Application Products
001 | CREAM, SUPPOSITORY;TOPICAL, VAGINAL | 2%,100MG | 0 | M-ZOLE 7 DUAL PACK | MICONAZOLE NITRATE |
FDA Submissions
| ORIG | 1 | AP | 1997-07-17 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1999-04-30 | |
LABELING; Labeling | SUPPL | 3 | AP | 2000-02-09 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2000-12-29 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 2002-01-08 | |
LABELING; Labeling | SUPPL | 6 | AP | 2002-11-21 | |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 5 | Null | 0 |
CDER Filings
ACTAVIS MID ATLANTIC
cder:Array
(
[0] => Array
(
[ApplNo] => 74586
[companyName] => ACTAVIS MID ATLANTIC
[docInserts] => ["",""]
[products] => [{"drugName":"M-ZOLE 7 DUAL PACK","activeIngredients":"MICONAZOLE NITRATE","strength":"2%,100MG","dosageForm":"CREAM, SUPPOSITORY;TOPICAL, VAGINAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"M-ZOLE 7 DUAL PACK","submission":"MICONAZOLE NITRATE","actionType":"2%,100MG","submissionClassification":"CREAM, SUPPOSITORY;TOPICAL, VAGINAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)